SCHEMBL17718016

SCHEMBL17718016

CCC1CC(NC(=O)N2CCn3nc(-c4ccc(F)c(Cl)c4)c(C(N)=O)c3C2)C1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CSNK1E P49674 20/20 0.59
▸ CSNK1D P48730 12/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17722435 0.91 CSNK1E (0.58) CSNK1ECSNK1D
SCHEMBL16701071 0.91 CSNK1E (0.62) CSNK1ECSNK1D
SCHEMBL16711373 0.90 CSNK1E (0.63) CSNK1ECSNK1D
SCHEMBL16711262 0.90 CSNK1E (0.63) CSNK1ECSNK1D
SCHEMBL17527358 0.90 CSNK1E (0.63) CSNK1ECSNK1D
SCHEMBL16708921 0.89 CSNK1E (0.64) CSNK1ECSNK1D
SCHEMBL16730859 0.89 CSNK1E (0.56) CSNK1ECSNK1D
SCHEMBL16700856 0.89 CSNK1E (0.59) CSNK1ECSNK1D
SCHEMBL16711372 0.89 CSNK1E (0.59) CSNK1ECSNK1D
SCHEMBL17527268 0.89 CSNK1E (0.59) CSNK1ECSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160122358-A1 NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2016-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122358-A1 NOVEL SUBSTITUTED PYRAZOLO-PIPERAZINES AS CASEIN KINASE 1 D/E INHIBITORS CSNK1E, CSNK1A1, CSNK1G1 CSNK1E 1/4885CSNK1D 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback